AstraZeneca slumps in London as earnings disappoint, vaccine profits modest

London stocks were under pressure Friday, and set for a modest weekly gain. Disappointing results from AstraZeneca and losses for resource names dragged on the main index.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.